Piper Sandler analyst Matt O’Brien raised the firm’s price target on Penumbra (PEN) to $330 from $250 and keeps an Overweight rating on the shares after the company reported Q4 results that beat consensus estimates on the top line. Full-year 2025 guidance was also established, just shy of consensus, though management outlined several key points that, to Piper, make the guidance relatively conservative.